Nuclear magnetic resonance (#NMR) and mass spectrometry (MS) are two commonly used, established methods for #narcotics analysis operating on fundamentally different scientific principles, thus providing definitive identification. Learn more: https://lnkd.in/d7tv3Kws #MassSpectrometry #ForensicAnalysis
Bruker BioSpin’s Post
More Relevant Posts
-
-> Read Blog: Utilizing advanced Nuclear Magnetic Resonance (NMR) technology - our latest research provides startling insights into MDMA content variability in street ecstasy tablets. This NMR-driven analytical accuracy sets a new standard in spectroscopy methods for #DrugAnalysis, significantly impacting harm reduction and public safety strategies. #Nanalysis #benchtopNMR #NMR #NMRchat https://lnkd.in/dC4E3NPu
Application of Benchtop NMR Spectroscopy in Illicit Substance Analysis: A Focus on MDMA — Nanalysis
nanalysis.com
-
PBL (Performing Beyond Limits) are known for their high-performance machines and have produced several world firsts in Packaging Machines and Inspection Systems. Check out their ingenious engineering applied in their Formulation and Dispensing “Hot-Cell” for Nuclear Medicine in this short video presentation. #southafrica #pharmaceuticalindustry #injectables #parenterals
Nuclear Medicine is a medical specialty involving the application of radioactive substances in the diagnosis and treatment of a variety of diseases. Specialized formulation and dispensing equipment is essential for safe formulation, dispensing, packing and inspection of these products. PBL’s N-R&D Integrated Formulation & Dispensing “Hot Cell” system featured in this video covers all your needs for safe and efficient production of Nuclear Medicines. IMAS INGENIOUS MACHINES proudly represents PBL in South Africa. Get in touch with Paul Adams 🇿🇦 or Lyn-Ann Adams of IMAS, or Andrea Gui of PBL, for more information. #southafrica #pharmaceuticalindustry #pharmaceuticalmanufacturing #injectables #parenterals #pharma #nuclearmedicine #radioactive
-
Nuclear Medicine is a medical specialty involving the application of radioactive substances in the diagnosis and treatment of a variety of diseases. Specialized formulation and dispensing equipment is essential for safe formulation, dispensing, packing and inspection of these products. PBL’s N-R&D Integrated Formulation & Dispensing “Hot Cell” system featured in this video covers all your needs for safe and efficient production of Nuclear Medicines. IMAS INGENIOUS MACHINES proudly represents PBL in South Africa. Get in touch with Paul Adams 🇿🇦 or Lyn-Ann Adams of IMAS, or Andrea Gui of PBL, for more information. #southafrica #pharmaceuticalindustry #pharmaceuticalmanufacturing #injectables #parenterals #pharma #nuclearmedicine #radioactive
-
📢 Exciting Update for Oncology Pharmacy Professionals! 📢 Dive into the latest chapter of the **Egyptian Guide for Oncology Pharmacy Practice, Volume II, Chapter II** - focused on **Nuclear and Radiological Safety: Principles and Practice of Nuclear Pharmacy**. Discover comprehensive insights on: ✅ Radiopharmaceutical fundamentals ✅ Essential radiation safety principles ✅ Regulatory frameworks ✅ Advanced preparation techniques ✅ Effective waste management ✅ Emergency preparedness ✅ Environmental and public safety Ensure you’re up-to-date with best practices and protocols to safeguard patients, healthcare workers, and the environment. Let's lead the way in safe and effective nuclear pharmacy practices! Stay informed, stay safe! 💊🔬🛡️ #OncologyPharmacy #NuclearPharmacy #Radiopharmaceuticals #RadiationSafety #PharmacyPractice #Healthcare #PatientSafety #PharmacyLeadership #EgyptianPharmacy
-
Médico Nuclear, Cardiologista, Coordenador Médico e Responsável Técnico do Serviço de Medicina Nuclear do HCor
In Brazil it is not different. We face a lot of regulations and it is urgent to discuss how to safely unlock the potential om Nuclear Medicine in our Latin America context, with so many infrastructure and logistics challenges in a Continental Country like ours. Congratulation’s European Association of Nuclear Medicine (EANM) and Dr Rudi Dierckx for the courage to face this challenge. We support this initiative and would like to learn from you how to develop something similar to our country and continent. This is also a concerning issue to SBMN . #strongertogether #medicinanuclear #nuclearmedicine
Turning the Tide – A Critical Call for Unlocking Nuclear Medicine Potential in Europe In the context of the revision of the EU Pharmaceutical Legislation, it is with great regret that the EANM and Nuclear Medicine Europe (NMEU) note that the recommendations of their joint proposals were omitted from the final position of the European Parliament. Our main concern is that this oversight risks hindering the regulatory framework for #radiopharmaceuticals, potentially impeding Europe's advancement in this crucial field. Now that the focus shifts to the Council of the EU, the EANM and NMEU urge policymakers to reconsider and prioritise developments in radiopharmaceuticals. ➡ Read our full joint statement to learn more about this pressing issue: https://lnkd.in/gY627MHs
-
-
The European Association of Nuclear Medicine (EANM) Annual Congress is getting closer! We are looking forward to attend the upcoming event with the latest innovations and news from our #ITELPHARMA Company, excited to represent the excellence of made in Italy in #radiopharmaceuticals. This year the global meeting will be held in #Hamburg, on October 19-23. See you there! Let's shape all together the future of #nuclearmedicine. #EANM #EANM24 #EANM2024 #radiotheranostics #theranostics #radiopharmacy #pharmaindustry #pharmaceuticalmarket #molecularimaging #radionuclidetherapy #radiationtherapy #pharmaceutical #clinicaltrials #radioisotopes #moleculartherapy
-
-
🗣 Discussions at the Council on the revision of the Pharma legislation continue. 🤝 EAHP shares the concerns raised by European Association of Nuclear Medicine (EANM) and Nuclear Medicine Europe in their joint communication. 💬 The changes proposed so far, despite being a step forward, do not reflect the tremendous technological advances in the field of radiopharmaceuticals and radionuclides. 📢 EAHP calls for keeping the attention high also on topics of relevance that sometimes tend to take a back seat in debates among policymakers. #radiopharmaceuticals
Turning the Tide – A Critical Call for Unlocking Nuclear Medicine Potential in Europe In the context of the revision of the EU Pharmaceutical Legislation, it is with great regret that the EANM and Nuclear Medicine Europe (NMEU) note that the recommendations of their joint proposals were omitted from the final position of the European Parliament. Our main concern is that this oversight risks hindering the regulatory framework for #radiopharmaceuticals, potentially impeding Europe's advancement in this crucial field. Now that the focus shifts to the Council of the EU, the EANM and NMEU urge policymakers to reconsider and prioritise developments in radiopharmaceuticals. ➡ Read our full joint statement to learn more about this pressing issue: https://lnkd.in/gY627MHs
-
-
Turning the Tide – A Critical Call for Unlocking Nuclear Medicine Potential in Europe In the context of the revision of the EU Pharmaceutical Legislation, it is with great regret that the EANM and Nuclear Medicine Europe (NMEU) note that the recommendations of their joint proposals were omitted from the final position of the European Parliament. Our main concern is that this oversight risks hindering the regulatory framework for #radiopharmaceuticals, potentially impeding Europe's advancement in this crucial field. Now that the focus shifts to the Council of the EU, the EANM and NMEU urge policymakers to reconsider and prioritise developments in radiopharmaceuticals. ➡ Read our full joint statement to learn more about this pressing issue: https://lnkd.in/gY627MHs
-
-
Thoughts on this? >> How to protect satellites against “killer electrons” >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #healthcare #biotech #pharma #productmarketing #pharmaceutical
How to protect satellites against “killer electrons”
economist.com
